Back
NYR
Nyrada Inc.
🇦🇺 ASX
📦 LOGISTICS
📈 HIGH PRICE GROWTH
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
+ 15.71%
Annual Growth
5 years average annual capital growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
2
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Nyrada, Inc. is a pre-clinical stage, drug discovery, and development company, which engages in the business of specializing in novel small molecule drugs to treat cardiovascular and neurological diseases. The company is headquartered in Gordon, New South Wales. The company went IPO on 2020-01-16. The firm is focused on the discovery and development of small-molecule therapies, specifically targeting Transient Receptor Potential Canonical (TRPC) ion channels. The Company’s lead candidate, Xolatryp, is a small molecule cardio protection and neuroprotection therapy. Xolatryp has demonstrated preclinical efficacy as an acute treatment following ischemic stroke, traumatic brain injury (TBI), and acute myocardial infarction (AMI). Xolatryp, is also a novel blocker targeting TRPC 3/6/7 ion channels, developed to mitigate secondary brain injury and prevent further brain cell death. The critical role of TRPC 3/6/7 channels in secondary injury has been validated in animal knockout models and through research-grade blockers. Its medical programs include Myocardial Ischemia and Arrhythmia Control, Stroke, and Traumatic Brain Injury.
📈 Performance
Price History
+87.50%
1M
1Y
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.38
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in NYR
2
📊 Total Capital Earnings
$675.22
🔃 Average investment frequency
20 weeks
💵 Average investment amount
$588
⏰ Last time a customer invested in NYR
34 days
NYR investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
50%
Less than 50k
50%
👶 Age of investors
18 - 25
50%
26 - 34
50%
35 - 90
🙋 Legal gender of investors
Female
Male
100%
Pearlers who invest in NYR also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
8.57%
📊 Share price
$112.91 AUD
💸 FINANCIALS
🧱 MATERIALS
⛳️ DIVERSIFIED
🇦🇺 AUSTRALIA
📈 HIGH PRICE GROWTH
VISM.AX was created on 2018-11-09 by Vanguard. The fund's investment portfolio concentrates primarily on small cap equity. The Vanguard MSCI International Small Companies Index ETF seeks to track the return of the MSCI World ex-Australia Small Cap Index in Australian dollars, before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
8.56%
📊 Share price
$74.56 AUD
⛳️ DIVERSIFIED
🌏 GLOBAL
📈 HIGH PRICE GROWTH
VEU.AX was created on 2009-05-12 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard All-World ex-US Shares Index ETF seeks to track the return of the FTSE All-World ex US Index before taking into account fees, expenses and tax
🙌 Performance (5Yr p.a)
10.54%
📊 Share price
$112.33 AUD
⛳️ DIVERSIFIED
📈 HIGH PRICE GROWTH
🌏 GLOBAL
QUAL.AX was created on 2014-10-29 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. Each Fund aims to provide investment returns before fees and other costs which track the performance of its Reference Index in Australian dollars.
🙌 Performance (5Yr p.a)
16.65%
📊 Share price
$61.95 AUD
📈 HIGH PRICE GROWTH
📞 COMMUNICATIONS
🤖 TECHNOLOGY
🌏 GLOBAL
VESG.AX was created on 2018-09-11 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Ethically Conscious International Shares Index ETF seeks to track the return of the FTSE Developed ex Australia Choice Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax
🙌 Performance (5Yr p.a)
17.26%
📊 Share price
$113.06 AUD
🌏 GLOBAL
🤖 TECHNOLOGY
⛳️ DIVERSIFIED
📈 HIGH PRICE GROWTH
Want more shares? Try these...
